| 1 |
Huang YS, Sun HY, Chang SY, Chuang YC, Su YC, Liu WC, Hung CC. Virological responses to tenofovir-alafenamide-containing antiretroviral therapy in people living with HIV co-infected with lamivudine-resistant or lamivudine-susceptible hepatitis B virus. Int J Antimicrob Agents 2022;60:106682. [PMID: 36279976 DOI: 10.1016/j.ijantimicag.2022.106682] [Reference Citation Analysis]
|
| 2 |
Obi JO, Gutiérrez-Barbosa H, Chua JV, Deredge DJ. Current Trends and Limitations in Dengue Antiviral Research. Trop Med Infect Dis 2021;6:180. [PMID: 34698303 DOI: 10.3390/tropicalmed6040180] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 3 |
Garay Quiroga J, Valdez Carrizo E. Hepatitis B y C en personas con VIH del instituto para el desarrollo humano. Rev Cient Cien Med 2021;24:122-126. [DOI: 10.51581/rccm.v24i1.337] [Reference Citation Analysis]
|
| 4 |
Tamandjou Tchuem CR, Brandt L, Nel ER, Cotton MF, Matthews P, Kaindjee-Tjituka F, Preiser W, Andersson MI. Hepatitis B virus drug resistance mutations in HIV/HBV co-infected children in Windhoek, Namibia. PLoS One 2020;15:e0238839. [PMID: 32915862 DOI: 10.1371/journal.pone.0238839] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 5 |
Gane EJ, Charlton MR, Mohamed R, Sollano JD, Tun KS, Pham TTT, Payawal DA, Gani RA, Muljono DH, Acharya SK, Zhuang H, Shukla A, Madan K, Saraf N, Tyagi S, Singh KR, Cua IHY, Jargalsaikhan G, Duger D, Sukeepaisarnjaroen W, Purnomo HD, Hasan I, Lesmana LA, Lesmana CRA, Kyi KP, Naing W, Ravishankar AC, Hadigal S. Asian consensus recommendations on optimizing the diagnosis and initiation of treatment of hepatitis B virus infection in resource-limited settings. J Viral Hepat 2020;27:466-75. [PMID: 31785182 DOI: 10.1111/jvh.13244] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 6 |
Morsica G, Galli L, Bossolasco S, Bagaglio S, Vercesi R, Salpietro S, Hasson H, Messina E, Castagna A, Uberti-Foppa C. Brief Report: Outcome of Acute Hepatitis B Virus Infection in HIV-1-Infected Patients: Possible Factors Associated With Resolution or Chronicity. J Acquir Immune Defic Syndr 2019;82:175-80. [PMID: 31192822 DOI: 10.1097/QAI.0000000000002106] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 7 |
Lin JJ, Lin KY, Tang HJ, Lin SP, Lee YC, Liu CE, Huang YS, Wang NC, Li CW, Ko WC, Yang HJ, Lee YT, Hung CC; Taiwan HIV Study Group. Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan. J Microbiol Immunol Infect 2021;54:228-37. [PMID: 31708481 DOI: 10.1016/j.jmii.2019.10.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Tsai WC, Hsu WT, Liu WD, Sun HY, Chuang YC, Huang YS, Cheng A, Lin KY, Huang YC, Chen GJ, Huang SH, Sheng WH, Hsieh SM, Hung CC, Chang SC. Impact of antiretroviral therapy containing tenofovir disoproxil fumarate on the survival of patients with HBV and HIV coinfection. Liver Int 2019;39:1408-17. [PMID: 30712284 DOI: 10.1111/liv.14059] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 9 |
Eyer L, Nencka R, de Clercq E, Seley-Radtke K, Růžek D. Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses. Antivir Chem Chemother 2018;26:2040206618761299. [PMID: 29534608 DOI: 10.1177/2040206618761299] [Cited by in Crossref: 79] [Cited by in F6Publishing: 87] [Article Influence: 19.8] [Reference Citation Analysis]
|
| 10 |
Huang YS, Sun HY, Chang SY, Chuang YC, Cheng A, Huang SH, Huang YC, Chen GJ, Lin KY, Su YC, Liu WC, Hung CC. Long-term virological and serologic responses of chronic hepatitis B virus infection to tenofovir disoproxil fumarate-containing regimens in patients with HIV and hepatitis B coinfection. Hepatol Int 2019;13:431-9. [PMID: 31177505 DOI: 10.1007/s12072-019-09953-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 11 |
Eyer L, Fojtíková M, Nencka R, Rudolf I, Hubálek Z, Ruzek D. Viral RNA-Dependent RNA Polymerase Inhibitor 7-Deaza-2'-C-Methyladenosine Prevents Death in a Mouse Model of West Nile Virus Infection. Antimicrob Agents Chemother 2019;63:e02093-18. [PMID: 30642926 DOI: 10.1128/AAC.02093-18] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 12 |
Eyer L, Fojtíková M, Nencka R, Rudolf I, Hubálek Z, Ruzek D. Viral RNA-dependent RNA polymerase inhibitor 7-deaza-2′-C-methyladenosine prevents death in a mouse model of West Nile virus infection.. [DOI: 10.1101/432955] [Reference Citation Analysis]
|
| 13 |
Bivigou-Mboumba B, Amougou-Atsama M, Zoa-Assoumou S, M'boyis Kamdem H, Nzengui-Nzengui GF, Ndojyi-Mbiguino A, Njouom R, François-Souquière S. Hepatitis B infection among HIV infected individuals in Gabon: Occult hepatitis B enhances HBV DNA prevalence. PLoS One 2018;13:e0190592. [PMID: 29315352 DOI: 10.1371/journal.pone.0190592] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 14 |
Tenofovir-disoproxil-fumarate. Reactions Weekly 2017;1643:283-283. [DOI: 10.1007/s40278-017-27756-2] [Reference Citation Analysis]
|
